RANKL is:
expressed on osteoclasts,
The functional activity of osteoblasts and osteoclasts is
synergistic and an imbalance may result in a variety of diseases,
including osteoporosis. Osteoblasts regulate osteoclasts via the
receptor activator of nuclear factor κ-B ligand (RANKL)-receptor
activator of nuclear factor κ-B (RANK) signaling pathway.
RANKL is a transmembrane protein expressed on the surface of
osteoblasts that can be shed from the plasma membrane by
osteoclast-derived MMP-7
- RANKL is found to be highly upregulated within the first 24 h
of fracture healing.
- This finding seems to contradict the primary role of RANKL as
an inducer of osteoclastogenesis and a marker of bone
remodeling.
- Early RANKL expression plays an important role in regulation of
immunologic response, specifically maturation and proliferation of
T helper cells, although little data exist to define its specific
function.
- Experiments in RANKL knockout animals have shown that
RANK/RANKL interaction within the immunologic niche is essential
for activation of Th cells, and maintenance of the local dendritic
cell population.
- In regards to RANKL’s early effect on the mesenchymal cell
population, osteoprotegerin (OPG) is also found to be highly
expressed during the same time period, likely negating RANKL’s
effect on osteoclast precursors, via competitive inhibition of
RANK.